QR Kodea

Seizure control by adding on other anti-seizure medication on seizure during levetiracetam administration in patients with glioma-related epilepsy

Abstract Background Epilepsy is a major symptom in patients with glioma. Levetiracetam (LEV) is recognized as a first-line treatment for glioma-related epilepsy. Increasing the LEV dose is allowed into patients with seizure occurrence against its initial dose. However, the therapeutic efficacy of in...

Deskribapen osoa

Gorde:
Egile Nagusiak: Etsuko Yamamoto Hattori, Yoshiki Arakawa, Yohei Mineharu, Keiko Furukawa, Yukinori Terada, Yukihiro Yamao, Masahiro Tanji, Takayuki Kikuchi, Susumu Miyamoto
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMC 2023-09-01
Saila:BMC Cancer
Gaiak:
Antiseizure medication
Levetiracetam
Glioma-related epilepsy
Seizure occurrence
Increasing dose
Sarrera elektronikoa:https://doi.org/10.1186/s12885-023-11273-8
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak